← Leaderboards
Wilfredo F Garcia-Beltran
Harvard Medical School
$1,614,193
Attributed
$1,614,193
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,614,193 · 2
By mechanism
DP2$1,457,050 · 1
F31$157,143 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Aedin C Culhane$2,653,443
- Jerome Timothy Galea$2,653,443
- Ann Chesney Miller$2,653,443
- Jeffrey R. Starke$2,653,443
- Lingyin Li$4,140,876
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsNatural Killer CellsMalignant NeoplasmsCell PhysiologyGenesImmuneInnovationIn VitroCytotoxicityAids/Hiv ProblemBiologicalAreaBiological ProcessAutoimmunityConfounding Factors (Epidemiology)CytokineCoculture TechniquesCell TypeAcquired Immunodeficiency SyndromeCollaborationsDisease ProgressionCd4 Positive T LymphocytesBiochemicalAlleles
Grant awards (5)
Harnessing natural killer cells for cellular immunotherapy against solid tumors$1,457,050
DP2 · FY2025 · CA · contact PI
Identifying the ligand for the activating NK cell receptor KIR3DS1 and its protective role in HIV-1 disease progression$36,348
F31 · FY2018 · AI · contact PI
Identifying the ligand for the activating NK cell receptor KIR3DS1 and its protective role in HIV-1 disease progression$49,044
F31 · FY2017 · AI · contact PI
Identifying the ligand for the activating NK cell receptor KIR3DS1 and its protective role in HIV-1 disease progression$36,311
F31 · FY2016 · AI · contact PI
Identifying the ligand for the activating NK cell receptor KIR3DS1 and its protective role in HIV-1 disease progression$35,440
F31 · FY2015 · AI · contact PI